INVITE - THE FUTURE OF CANNABIS IS INTERSTATE COMMERCE
CALL DETAILS:
|
We will host a call with Adam J. Smith, the Alliance for Sensible Markets president. To talk about how he sees the future of interstate commerce in the Cannabis industry.
In our deck and the call, we will address some of the following:
- The Cannabis Dilemma
- States take a leadership role
- Improving basic economics
- Proof of concept
- Implications of Industry benefits and challenges.
California's governor is reshaping the industry by beginning to give a lifeline to all the "consuming" states by lowering the cost of goods to allow for the industry's success and jump-start the failing state-led social equity programs.
AYR Award-Winning Brand.
Ayr Wellness (AYRWF) announced today the launch of Lost in Translation (LIT), an award-winning cannabis brand known for sought-after genetics and terpene profiles, across four additional states in Ayr’s operational footprint: Arizona, Florida, New Jersey, and Pennsylvania. Lost in Translation is now available in six states, including Massachusetts and its home state of Nevada. Originally produced by six-time Jack Herer Cup-winning cultivators Tahoe Hydroponics Company (“Tahoe Hydro”), Lost in Translation has made its name with consumers through its extensive library of well-known strains with unique flavors and aromas, including Bubble Bath, WAP, and Temptation. Recently featured in High Times, Lost in Translation reflects Ayr’s commitment to high-quality cannabis at scale. “We’re proud of the flower we’re growing throughout our footprint and are excited by the opportunity to delight our customers with a combination of quality flower and award-winning genetics,” said Jonathan Sandelman, Founder and CEO of Ayr Wellness. “The rollout of a brand for cannabis connoisseurs like Lost in Translation reiterates Ayr’s commitment to its strategic brand portfolio that meets our patients and customers wherever they are in their cannabis journey. The flower remains the predominant method of consumption across the country, so it is important to have brands that range from value to premium, including Road Tripper, Kynd, and now LIT.”
Tilray Heads to Italy.
Tilray Brands (TLRY) today said the Italian Ministry of Health has approved Tilray-branded medical cannabis for pharmaceutical distribution. The company said that FL Group S.R.L., a division of Tilray Medical in Italy, received approval from the ministry to import and distribute the medical cannabis oral solution THC25 across the country. Tilray Medical has an established pharmaceutical distribution network in Italy, where medical cannabis authorization is limited, the company said.
